Meeting
2019 Genitourinary Cancers Symposium
Prognostic value of loss of chromosome 10q in patients with localized renal cell carcinoma.
Authors
Cedric Michel Lebacle
Institute of Urologic Oncology (IUO), Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA Service d’urologie CHU Bicêtre, APHP, Université Paris-Sud Paris Saclay, Le Kremlin Bicetre, France
Cedric Michel Lebacle , Aydin Pooli , Nagesh Rao , Erika Louise Wood , Nils Kroeger , Sandy Liu , Izak Faiena , Karim Chamie , Arie S. Belldegrun , Brian Shuch , Alexandra Drakaki , Allan J. Pantuck
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 626)
DOI
10.1200/JCO.2019.37.7_suppl.626
Abstract #
626
Poster Bd #
G21
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Disease-free survival as a predictor of overall survival in localized renal cell carcinoma (RCC) following first nephrectomy.
First Author: Naomi B. Haas
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Predicting recurrence using a tumor-uninformed ctDNA assay detecting MRD in patients with resected stage II or III colorectal cancer: Subset analysis from the GALAXY study in CIRCULATE-Japan.
First Author: Yoshiaki Nakamura
Poster
2023 ASCO Annual Meeting
Circulating tumor DNA dynamics as an early predictor of recurrence in patients with radically resected colorectal cancer: Updated results from GALAXY study in the CIRCULATE-Japan.
First Author: Eiji Oki
Poster
2023 ASCO Annual Meeting
Clinical and financial implications of ADUARA trial on a real-world population.
First Author: Bharathi Muthusamy